| Cambridge Heart to Participate in MTWA Webinar |
|
TEWKSBURY, Mass., Feb 18, 2011 (BUSINESS WIRE) -- Cambridge Heart, Inc. (OTCBB: CAMH), a developer of non-invasive diagnostic tests for cardiac disease, today announced that Dr. Michael Mirro, an electrophysiologist at Fort Wayne Cardiology and Medical Director of the Parkview Research Center, will lead a Webinar entitled "Enhancing the Value of your Cardiac Stress Lab with Microvolt T-Wave Alternans". The discussion topics will include an overview of MTWA technology and benefits, how to incorporate MTWA into a cardiac testing protocol, treatment options to prevent Sudden Cardiac Arrest and the reimbursement landscape for MTWA. The webinar, sponsored by Cardiac Science, is targeted at clinicians and administrators, and is scheduled for 3:00 PM, EST February 22nd. Participants can register for the webinar at https://budurl.com/MTWAx. Questions can be directed to the Company's management or its investor relations firm at the contact numbers noted above. About Cambridge Heart, Inc. Cambridge Heart develops and commercializes non-invasive diagnostic tests for cardiac disease, with a focus on identifying those at risk for sudden cardiac arrest (SCA). The Company's products incorporate proprietary Microvolt T-Wave Alternanstm measurement technologies, including the patented Analytic Spectral Method(R) and ultrasensitive disposable electrode sensors. The Company's MTWA test, originally based on research conducted at the Massachusetts Institute of Technology, is reimbursed by Medicare under its National Coverage Policy. Cambridge Heart, founded in 1990, is based in Tewksbury, MA. It is traded on the Over-The-Counter Bulletin Board (OTCBB) under the symbol CAMH.OB. Statements contained in this press release that are not purely historical are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995.In some cases, we use words such as "believes", "expects", "anticipates", "plans", "estimates", "could", and similar expressions that convey uncertainty of future events or outcomes to identify these forward-looking statements.Actual results may differ materially from those indicated by these forward-looking statements.Factors that may cause or contribute to such differences are identified in our most recent Annual Report on Form 10-K under "Risk Factors", which is on file with the SEC and available at www.EDGAR.com.In addition, any forward-looking statements represent our estimates only as of today and should not be relied upon as representing our estimates as of any subsequent date.While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so except as may be legally necessary, even if our estimates should change. SOURCE: Cambridge Heart, Inc. At Cambridge Heart: |
